Sign in
SCHEDULE 13D/A

Beneficial Ownership Report

Q/C TECHNOLOGIES, INC. Filed Acc 0001683168-26-009020

Stakes reported in this filing

Reporting person Shares Of the class
PharmaCyte Biotech, Inc. 8,446,093 49.99%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13D_X02/primary_doc.xml…